高胰岛素血症及胰岛素抵抗的研究进展
Research Progress on Hyperinsulinemia and Insulin Resistance
DOI: 10.12677/hjbm.2024.143039, PDF,   
作者: 黎玉婷, 林显光, 李臣鸿*：中南民族大学生物医学工程学院，湖北 武汉
关键词: 高胰岛素血症；胰岛素抵抗；NOS；cAMP-PKA；PI3K-PKB(Akt)；Hyperinsulinemia； Insulin Resistance； NOS； cAMP-PKA； PI3K-PKB (Akt)
摘要: 高胰岛素血症及胰岛素抵抗是2型糖尿病和肥胖的主要代谢特征，可由遗传和生活方式等因素导致。二者在部分癌症的发生发展过程中可能起重要促进作用。本文就高胰岛素血症和胰岛素抵抗的关系，和所涉及的部分通路以及两者对其它癌症的影响进行综述，为研发新型缓解药物提供依据。
Abstract: Hyperinsulinemia and insulin resistance are the main metabolic features of type 2 diabetes and obesity, which can be caused by genetic and lifestyle factors. The two may play an important role in the occurrence and development of some cancers. This article reviews the relationship between hyperinsulinemia and insulin resistance, some of the pathways involved, and the effects of the two on other cancers, so as to provide a basis for the development of new remission-seeking drugs.
文章引用：黎玉婷, 林显光, 李臣鸿. 高胰岛素血症及胰岛素抵抗的研究进展[J]. 生物医学, 2024, 14(3): 353-358. https://doi.org/10.12677/hjbm.2024.143039

参考文献

[1] Freeman, A.M. and Pennings, N. (2021) Insulin Resistance. StatPearls, Treasure Island.
[2] Gallagher, E.J. and LeRoith, D. (2020) Hyperinsulinaemia in Cancer. Nature Reviews Cancer, 20, 629-644. [Google Scholar] [CrossRef] [PubMed]
[3] 李珊珊, 赵钰岚. 胰岛素抵抗及高胰岛素血症促进胰腺癌发生的研究进展[J]. 预防医学, 2021, 33(11), 1122-1125, 1129. [Google Scholar] [CrossRef] 
[4] Thomas, D.D., Corkey, B.E., Istfan, N.W., et al. (2019) Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. Journal of the Endocrine Society, 3, 1727-1747. [Google Scholar] [CrossRef] [PubMed]
[5] Rose, D.P., Gracheck, P.J. and Vona-Davis, L. (2015) The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer. Cancers, 7, 2147-2168. [Google Scholar] [CrossRef] [PubMed]
[6] Newton. C.A. and Raskin, P. (2004) Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences. Archives of Internal Medicine, 164, 1925-1931. [Google Scholar] [CrossRef] [PubMed]
[7] Fujita, N., Aono, S., Karasaki, K., et al. (2018) Changes in Lipid Metabolism and Capillary Density of the Skeletal Muscle Following Low-Intensity Exercise Training in a Rat Model of Obesity with Hyperinsulinemia. PLOS ONE, 13, e0196895. [Google Scholar] [CrossRef] [PubMed]
[8] Huang, S., Ma, S., Ning, M., et al. (2019) TGR5 Agonist Ameliorates Insulin Resistance in Skeletal Muscles and Improves Glucose Homeostasis in Diabetic Mice. Metabolism, 99, 45-56. [Google Scholar] [CrossRef] [PubMed]
[9] Page, M.M. and Johnson, J.D. (2018) Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance. Trends in Endocrinology & Metabolism, 29, 389-399. [Google Scholar] [CrossRef] [PubMed]
[10] Manco., M., Nolfe., G., Pataky., Z., et al. (2017) Shape of the OGTT Glucose Curve and Risk of Impaired Glucose Metabolism in the EGIR-RISC Cohort. Metabolism: Clinical and Experimental, 70, 42-50. [Google Scholar] [CrossRef] [PubMed]
[11] Hall, C., Yu, H. and Choi, E. (2020) Insulin Receptor Endocytosis in the Pathophysiology of Insulin Resistance. Experimental & Molecular Medicine, 52, 911-920. [Google Scholar] [CrossRef] [PubMed]
[12] Pinkney, J.H., Stehouwer, C.D., Coppack, S.W., et al. (1997) Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome. Diabetes, 46, S9-S13. [Google Scholar] [CrossRef] 
[13] Ashcroft, F.M., Harrison, D.E. and Ashcroft, S.J. (1984) Glucose Induces Closure of Single Potassium Channels in Isolated Rat Pancreatic β-Cells. Nature, 312, 446-448. [Google Scholar] [CrossRef] [PubMed]
[14] 翟中和, 王喜忠, 丁明孝. 细胞生物学[M]. 北京: 高等教育出版社, 2011: 170-180.
[15] Liu, R., Guan, S., Gao, Z., et al. (2021) Pathological Hyperinsulinemia and Hyperglycemia in the Impaired Glucose Tolerance Stage Mediate Endothelial Dysfunction through MiR-21, PTEN/AKT/ENOS, and MARK/ET-1 Pathways. Frontiers in Endocrinology, 12, Article 644159. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Z., Feng, P.P., Zhao, Z.B., et al. (2019) Liraglutide Protects against Inflammatory Stress in Non-Alcoholic Fatty Liver by Modulating Kupffer Cells M2 Polarization via CAMP-PKA-STAT3 Signaling Pathway. Biochemical and Biophysical Research Communications, 510, 20-26. [Google Scholar] [CrossRef] [PubMed]
[17] Akerstrom, T., Goldman, D., Nilsson, F., et al. (2020) Hyperinsulinemia Does Not Cause de Novo Capillary Recruitment in Rat Skeletal Muscle. Microcirculation, 27, e12593. [Google Scholar] [CrossRef] [PubMed]
[18] Jeon, J.Y., Choi, S.E., Ha, E.S., et al. (2019) GLP1 Improves Palmitate-Induced Insulin Resistance in Human Skeletal Muscle via SIRT1 Activity. International Journal of Molecular Medicine, 44, 1161-1171. [Google Scholar] [CrossRef] [PubMed]
[19] Holman, G.D. (2020) Structure, Function and Regulation of Mammalian Glucose Transporters of the SLC2 Family. Pflügers Archiv—European Journal of Physiology, 472, 1155-1175. [Google Scholar] [CrossRef] [PubMed]
[20] Gao, Z., Song, G.Y., Ren, L.P., et al. (2020) β-Catenin Mediates the Effect of GLP-1 Receptor Agonist on Ameliorating Hepatic Steatosis Induced by High Fructose Diet. European Journal of Histochemistry, 64, 225-233. [Google Scholar] [CrossRef] [PubMed]
[21] Li, H., Cao, L., Ren, Y., et al. (2018) GLP-1 Receptor Regulates Cell Growth through Regulating IDE Expression Level in Aβ1-42-Treated PC12 Cells. Bioscience Reports, 38, BSR20171284. [Google Scholar] [CrossRef] 
[22] Guilherme, A., Henriques, F., Bedard, A.H., et al. (2019) Molecular Pathways Linking Adipose Innervation to Insulin Action in Obesity and Diabetes Mellitus. Nature Reviews Endocrinology, 15, 207-225. [Google Scholar] [CrossRef] [PubMed]
[23] Lee, C.L. and Kuo, H.C. (2017) Pathophysiology of Benign Prostate Enlargement and Lower Urinary Tract Symptoms: Current Concepts. Tzu Chi Medical Journal, 29, 79-83. [Google Scholar] [CrossRef] [PubMed]
[24] Cen, H.H., Botezelli, J.D., Wang, S., et al. (2021) Transcriptomic Analysis of Human and Mouse Muscle during Hyperinsulinemia Demonstrates Insulin Receptor Downregulation as a Mechanism for Insulin Resistance. bioRxiv: 556571.
[25] Bär, L., Feger, M., Fajol, A., et al. (2018) Insulin Suppresses the Production of Fibroblast Growth Factor 23 (FGF23). Proceedings of the National Academy of Sciences of the United States of America, 115, 5804-5809. [Google Scholar] [CrossRef] [PubMed]
[26] Dev, R., Bruera, E. and Dalal, S. (2018) Insulin Resistance and Body Composition in Cancer Patients. Annals of Oncology, 29, II18-II26. [Google Scholar] [CrossRef] [PubMed]
[27] Honors, M.A. and Kinzig, K.P. (2012) The Role of Insulin Resistance in the Development of Muscle Wasting during Cancer Cachexia. Journal of Cachexia, Sarcopenia and Muscle, 3, 5-11. [Google Scholar] [CrossRef] [PubMed]
[28] Dev, R., Del Fabbro, E. and Dalal, S. (2019) Endocrinopathies and Cancer Cachexia. Current Opinion in Supportive and Palliative Care, 13, 286-291. [Google Scholar] [CrossRef] 
[29] Kidd, A.C., Skrzypski, M., Jamal-Hanjani, M., et al. (2019) Cancer Cachexia in Thoracic Malignancy: A Narrative Review. Current Opinion in Supportive and Palliative Care, 13, 316-322. [Google Scholar] [CrossRef] 
[30] Wang, X., Yan, C. and Liu, J. (2019) Hyperinsulinemia-Induced KLF5 Mediates Endothelial Angiogenic Dysfunction in Diabetic Endothelial Cells. Journal of Molecular Histology, 50, 239-251. [Google Scholar] [CrossRef] [PubMed]
[31] Janssen, J.A. (2021) Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International Journal of Molecular Sciences, 22, Article 7797. [Google Scholar] [CrossRef] [PubMed]
[32] Kim, N.H., Chang, Y., Lee, S.R., et al. (2020) Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer Mortality in Individuals with and without Diabetes. Official Journal of the American College of Gastroenterology, 115, 1840-1848. [Google Scholar] [CrossRef] [PubMed]
[33] Nasiri, A.R., Rodrigues, M.R., Li, Z., et al. (2019) SGLT2 Inhibition Slows Tumor Growth in Mice by Reversing Hyperinsulinemia. Cancer & Metabolism, 7, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, Y., Nasiri, A.R., Damsky, W.E., et al. (2018) Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer. Cell Reports, 24, 47-55. [Google Scholar] [CrossRef] [PubMed]
[35] Nishimura, Y., Musa, I., Holm, L., et al. (2021) Recent Advances in Measuring and Understanding the Regulation of Exercise-Mediated Protein Degradation in Skeletal Muscle. American Journal of Physiology-Cell Physiology, 321, C276-C287. [Google Scholar] [CrossRef] [PubMed]
[36] Kullmann, S., Hummel, J., Wagner, R., et al. (2022) Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial. Diabetes Care, 45, 398-406. [Google Scholar] [CrossRef] [PubMed]

为你推荐